Selskabets formål er at udvikle og kommercialisere værktøjer til genetiske analyser og behandlinger baseret på modificerede oligonukleotider samt anden dermed beslægtet virksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 7.1 mio. | -5.6 mio. | 66.8 mio. | 54.1 mio. | 23 | |
CVR: 30197852
Previous names: PENTABASE ApS
1 properties
Upgrade to Pro to see addresses, building data and ownership details
Compared to 998 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Torben Storgaard Guldberg joined the board
PENTABASE A/S registered with 5% ownership
BDO Statsautoriseret Revisionspartnerselskab appointed as auditor
A/S PSE 17 NR. 1056 resigned as auditor
Companies in the same industry and area
CVR 38734482
CVR 40480331
CVR 43082108
CVR 42559997
CVR 29410100
companydata.dk